Skip to main content
. 2024 Apr 3;13(4):e1504. doi: 10.1002/cti2.1504

Figure 4.

Figure 4

Schematic of IBM inclusion criteria. Criteria include a combination of clinical, histopathological and laboratory findings (serology for autoantibodies against cN1A). Our total cohort consisted of 81 IBM patients. This figure was created using BioRender.com.